Clinical Trials Market Size Share Growth Analysis Trend 2020 202 The global clinical trials market size was valued at usd 80.7 billion in 2023 and is projected to grow at a compound annual growth rate (cagr) of 6.49% from 2024 to 2030. the market growth spiked in 2020 owing to the covid 19 pandemic. this growth pattern was witnessed by both virtual clinical trials and traditional ones. The clinical trials market is estimated to cross us$ 83.5 bn by the end of 2030. however, finding the right patients is one of the most important pieces of the puzzle with respect to conducting clinical trials. hence, stakeholders are working with experts at clinical trial recruitment companies to match patients with the right trials.
Neurology Clinical Trials Market To Witness Geometric Growth With Usd 7 Data bridge market research analyzes that the global clinical trials market which was usd 269.18 million in 2022, is likely to reach usd 402.28 million by 2030, and is expected to undergo a cagr of 5.15% during the forecast period. “laboratories" dominates the end segment of the clinical trials market due to increase in the number of research. The u.s. clinical trials market was valued at usd 22.6 billion in 2021 and is expected to expand at a compound annual growth rate (cagr) of 5.4% from 2022 to 2030. the growth is majorly driven by a rise in r&d activities, increasing vaccine trials, the need for personalized medicine, and the growing use of new technologies across clinical research. Clinical trials market size was valued at usd 46.8 billion in the year 2023 and is anticipated to grow usd 70.23 bn by 2030 at a cagr of 7.5% from 2024 2030. clinical trials are research studies primarily performed on humans to get data about the safety and efficacy of newer biomedical interventions including novel devices, vaccines, drugs, and. The north america clinical trials market size was estimated at usd 40.9 billion in 2023 and is projected to grow at a compound annual growth rate (cagr) of 5.99% from 2024 to 2030. this is attributed to increasing clinical trial cycles, the need for novel therapies, a surge in chronic diseases such as cancer, diabetes, and infectious diseases.
Comments are closed.